Sort
261,768 grants matching “gene therapy”
Identification and functional characterization of colorectal cancer genes
$934,717Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Animal Models of Diabetic Vascular Disease
$934,670Rockefeller University · U01 · FY2005 · HL
Sample collection for systems evaluation of patients with unknown or incompletely characterized immune defects
$934,658Rachel Sparks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
$934,594Jennifer R Grandis · University Of California, San Francisco · R35 · FY2019 · CA
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$934,584Allan D. Kirk · Emory University · U01 · FY2012 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$934,552Michael R. Farzan · Scripps Florida · R37 · FY2019 · AI
GENOMICS OF HUMAN CANCER
$934,450Cold Spring Harbor Laboratory · R01 · FY2001 · CA
Cadaveric Donor Lung and Bone Marrow Transplantation in Immunodeficiency Diseases
$934,439Paul Szabolcs · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · AI
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy
$934,438Lei Zhu · Migra-Therapeutics, Llc · R44 · FY2022 · CA
SIRT1 in Skeletal Muscle Development, Regeneration, and Atrophy
$934,350Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
THE PHARMACODYNAMICS OF GENES AND OLIGONUCLEOTIDES
$934,303University Of North Carolina Chapel Hill · P01 · FY2003 · GM
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array
$934,299Benjamin Jacob Doranz · Integral Molecular · R44 · FY2020 · GM
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
$934,250Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2014 · CA
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
$934,220Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
T-cell receptor gene therapy for human papillomavirus-positive cancers
$934,220Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
$934,192Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer
$934,152Martha Or Marty L Slattery · University Of Utah · R01 · FY2007 · CA
SIRT1 in Skeletal Muscle Development, Regeneration, and Atrophy
$934,019Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Strategies for Prevention of Autoimmunity
$934,000Stanford University · U19 · FY2005 · DK
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$933,896Darell D Bigner · Duke University · R35 · FY2016 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$933,882Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A multivalent, easy-to-use product to mitigate and treat radiation exposure
$933,782Richard Yen · Fibroplate, Inc. · R44 · FY2020 · AI
MICROCHIP DRUG DELIVERY SYSTEM
$933,759Massachusetts Institute Of Technology · R24 · FY2003 · AI
Reversing Cellular immortality in cancer
$933,706Steven E Artandi · Stanford University · R35 · FY2019 · CA
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
$933,572Jack A. Syage · Immunogenics, Llc · R44 · FY2021 · DK